Coelovirin D



Compound IDCDAMM03036
Common nameCoelovirin D
IUPAC name2-[1-hydroxy-2-oxo-2-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]ethyl]-3-methyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid
Molecular formulaC27H40O17

Experimental data

Retention time3.51
Adduct[M+K]+
Actual mz675.181
Theoretical mz675.19
Error13.27
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7761

Identifiers and class information

Inchi keyWDUSVQPERDZPMH-HTMDZYJANA-N
SmilesO=C(O)C(OC1OC(CO)C(O)C(O)C1O)(C(O)C(=O)OCC2=CC=C(OC3OC(CO)C(O)C(O)C3O)C=C2)C(C)CC
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Plant source

  • Clitoria ternatea L.

    • Pharmacokinetic properties

    Number of descriptor values(#stars)10
    Number of non-conjugated amine groups (#amine)0
    Number of amidine and guanidine groups (#amidine)0
    Number of carboxylic acid groups (#acid)1
    Number of non-conjugated amide groups (#amide)0
    Number of rotatable bonds (#rotor)22
    Number of reactive functional groups (#rtvFG)3
    Predicted central nervous system activity (CNS)-2
    Molecular weight (mol_MW)636.603
    Computed dipole moment(dipole)5.811
    Total solvent accessible surface area (SASA)797.283
    Hydrophobic component of SASA (FOSA)345.817
    Hydrophilic component of SASA (FISA)362.111
    Pie component of the SASA (PISA)89.354
    Weakly polar component of the SASA (WPSA)0
    Total solvent accesible volume (volume)1659.1
    Number of hydrogen bond donors (donorHB)9
    Number of hydrogen bond acceptors (accptHB)23.2
    Free energy of solvation of dipole (dip^2/V)0.0203562
    Index of cohesive interaction in solids (ACxDN^.5/SA)0.0872965
    Globularity descriptor (glob)0.850095
    Predicted polarizability in cubic angstroms (QPpolrz)46.97
    Predicted hexadecane/gas partition coefficient (QPlogPC16)18.534
    Predicted octanol/gas partition coefficient (QPlogPoct)42.149
    Predicted water/gas partition coefficient (QPlogPw)35.889
    Predicted octanol/water partition coefficient (QPlogPo/w)-1.892
    Predicted aqueous solubility (QPlogS)-0.708
    Conformation-independent predicted aqueous solubility (CIQPlogS)-3.091
    Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.576
    Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.924
    Predicted brain/blood partition coefficient (QPlogBB)-4.103
    Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.33
    Predicted skin permeability, log Kp (QPlogKp)-5.766
    PM3 calculated ionization potential (IP(ev))9.483
    PM3 calculated electron affinity (EA(eV))0.091
    Number of likely metabolic reactions (#metab)10
    Prediction of binding to human serum albumin (QPlogKhsa)-1.743
    Predicted qualitative human oral absorption (HumanOralAbsorption)1
    Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
    Solvent-accessible surface area of fluorine atoms (SAFluorine)0
    Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
    Van der Waals surface area (PSA)271.334
    Number of nitrogen and oxygen atoms (#NandO)17
    Number of violations of Lipinski’s rule of five (RuleOfFive)3
    Number of violations of Jorgensen’s rule of three (RuleOfThree)2

    Compound-target network

    Cytoscape Graph

    Protein targets associated with phytocompound

    Uniprot ID Gene name Target name TTD_ID Prediction source
    O43570CA12Carbonic anhydrase XIIT16987SEA
    Q16790CA9Carbonic anhydrase IXT64567SEA
    P17655CAPN2Calpain 2T86837SEA
    P15692VEGFAVascular endothelial growth factor AT20761SEA
    P05230FGF1Acidic fibroblast growth factorT18639SEA
    P09038FGF2Basic fibroblast growth factorT31621SEA
    P01112HRASTransforming protein p21/H-Ras-1T71081SEA
    P60568IL2Interleukin-2T61698SEA
    Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
    P17931LGALS3Galectin-3T72038SEA
    P14679TYRTyrosinaseT97035SEA
    Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
    P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

    Target associated diseases

    TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
    T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
    T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
    T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
    T86837DI0106COVID-19[ICD-11: 1D6Y]P17655CAPN2
    T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
    T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
    T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
    T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
    T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
    T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
    T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
    T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
    T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
    T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
    T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
    T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
    T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
    T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
    T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
    T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

    Copyright © 2025